Showing 1,701 - 1,720 results of 3,189 for search '"vaccine"', query time: 0.05s Refine Results
  1. 1701

    A lyophilised formulation of chimpanzee adenovirus vector for long-term stability outside the deep-freeze cold chain by Frédéric Mathot, Edwige Lefebvre, Bernard G. Francq, Delphine Guillaume, Erwan Bourlès

    Published 2025-01-01
    “…Abstract Background The adenovirus-vaccine platform has come to prominence with the COVID-19 vaccination campaigns. …”
    Get full text
    Article
  2. 1702

    Canada's First Universal Varicella Immunization Program: Lessons from Prince Edward Island by Lamont Sweet, Peggy Gallant, Marie Morris, Scott A Halperin

    Published 2003-01-01
    “…Repeated media announcements and the cooperation of staff in schools and daycare facilities assisted in informing parents about the availability of the vaccine. Vaccine- associated adverse events have been uncommon and the vaccine has been well accepted.…”
    Get full text
    Article
  3. 1703

    QAAPT: an interoperable web-based open-source tool for antimicrobial resistance data analysis and visualisation by Mohammad Julhas Sujan, Sanjay Gautam, Ahmed Taha Aboushady, Adam Clark, Sooyoung Kwon, Hea Sun Joh, Marianne Holm, John Stelling, Florian Marks, Florian Marks, Florian Marks, Florian Marks, Nimesh Poudyal

    Published 2025-02-01
    “…The QAAPT tool was created by the Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia project, led by the International Vaccine Institute (IVI). This open-source web-based tool/application generates statistical and visual outputs of AMR data, offers data curation options, and can be integrated with laboratory information management systems. …”
    Get full text
    Article
  4. 1704

    Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use by J. M. J. Van den Bergh, E. L. J. M. Smits, M. Versteven, H. De Reu, Z. N. Berneman, V. F. I. Van Tendeloo, E. Lion

    Published 2017-01-01
    “…Personalized dendritic cell- (DC-) based vaccination has proven to be safe and effective as second-line therapy against various cancer types. …”
    Get full text
    Article
  5. 1705

    Automatic Generation of Validated Specific Epitope Sets by Sebastian Carrasco Pro, John Sidney, Sinu Paul, Cecilia Lindestam Arlehamn, Daniela Weiskopf, Bjoern Peters, Alessandro Sette

    Published 2015-01-01
    “…Accurate measurement of B and T cell responses is a valuable tool to study autoimmunity, allergies, immunity to pathogens, and host-pathogen interactions and assist in the design and evaluation of T cell vaccines and immunotherapies. In this context, it is desirable to elucidate a method to select validated reference sets of epitopes to allow detection of T and B cells. …”
    Get full text
    Article
  6. 1706

    Sensitivity and Optimal Control Analysis of an Extended SEIR COVID-19 Mathematical Model by C. M. Wachira, G. O. Lawi, L. O. Omondi

    Published 2022-01-01
    “…The sensitivity analysis carried out on this model showed that the vaccination rate and vaccine efficacy are among the most sensitive parameters of the vaccine reproduction number, RV. …”
    Get full text
    Article
  7. 1707
  8. 1708

    Analysis of Production Function in Layer Chicken Business in Soppeng District by Hasraful Anang, Syahriadi Kadir

    Published 2025-01-01
    “…Independent variables consisted of seedlings, labor, cage area, farmer experience, Newcastle Disease (ND) vaccine, Avian Influenza (AI) vaccine, concentrate feed, ground corn feed and bran feed. …”
    Get full text
    Article
  9. 1709

    Increased Chemokine Production is a Hallmark of Rhesus Macaque Natural Killer Cells Mediating Robust Anti-HIV Envelope-Specific Antibody-Dependent Cell-Mediated Cytotoxicity by Junsuke Nohara, Tyler Evangelous, Madison Berry, Whitney Beck, Sarah Mudrak, Shalini Jha, R. Keith Reeves, Kevin J. Wiehe, Justin Pollara, Georgia Tomaras, Todd Bradley, Guido Ferrari

    Published 2025-01-01
    “… Background: Antibody-dependent cell-mediated cytotoxic (ADCC) response mediated by natural killer (NK) cells correlates with decreased infection risk in studies involving simian immunodeficiency virus (SIV)/simian-human immunodeficiency virus (SHIV), and human immunodeficiency virus (HIV) vaccine candidates. Currently, the heterogeneities of the functional subset of rhesus macaque natural killer (RMNK) cells are under-characterized.  …”
    Get full text
    Article
  10. 1710

    Population-Based Surveillance of HiB Invasive Infections in Children in British Columbia, Alberta and Ontario -- 1995 to 1997 by David Scheifele, Alison Bell, Taj Jadavji, Wendy Vaudry, John Waters, Monika Naus, Jill Sciberras

    Published 2000-01-01
    “…OBJECTIVE: To assess vaccine effectiveness through enhanced disease surveillance following the change in childhood immunization programs in 1995, when all provinces and territories chose to use polyribosyl ribitol phosphate-tetanus protein (PRP-T) Haemophilus influenzae type b (Hib) conjugate vaccine, generally in combination with diphtheria-pertussis-tetanus inactivated polio vaccine (DPT-IPV) (as PENTA vaccine) because the protective efficacy of this regimen had not been directly measured.…”
    Get full text
    Article
  11. 1711

    Characterisation of clinical response and transcriptional profiling of proliferating CD8 T cells in the blood of cancer patients after PD-1 monotherapy or combination therapy by Peng Li, Haydn Kissick, Rebecca C Obeng, Tahseen H Nasti, Christiane S Eberhardt, Rafi Ahmed, Zhengjia Chen, Warren J Leonard, Suresh S Ramalingam, Andreas Wieland, Annapaola Mariniello, Jeffrey M Switchenko, Kylee Martens, Daniel Y Chang, Donald McGuire, Candace Daugherty, Yuzi Zhang, Rathi Pillai, Alice O Kamphorst

    Published 2024-07-01
    “…Transcriptional analysis of CD8 T cells after the first treatment cycle with effector cells generated following yellow fever virus (YFV-17D) vaccine-induced infection was also compared.Results An early proliferative (Ki-67+) CD8 T-cell response was observed after cycle 1 in 60 patients (58.3%). …”
    Get full text
    Article
  12. 1712

    Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza by Olivia Prosper, Omar Saucedo, Doria Thompson, Griselle Torres-Garcia, Xiaohong Wang, Carlos Castillo-Chavez

    Published 2010-12-01
    “…Nations capable of acquiring large vaccine supplies soon became aware that those who could pay would have to compete for a limited vaccine stockpile. …”
    Get full text
    Article
  13. 1713

    Efficacy of Rg1-Oil Adjuvant on Inducing Immune Responses against Bordetella bronchiseptica in Rabbits by Xiao Chenwen, Ji Quanan, Huang Yee, Liu Yan, Wang Jiaoyu, Wei Qiang, Qiao Litao, Nan Li, Bao Guolian

    Published 2021-01-01
    “…This study is aimed at examining the immune effects of Rg1, Rg1 plus oil, and other common adjuvants on inactivated B. bronchiseptica vaccine in rabbits. The mechanism underlying the adjuvant effect of Rg1 plus oil on the vaccine was also explored. …”
    Get full text
    Article
  14. 1714

    Cytomegalovirus in the Neonate: Immune Correlates of Infection and Protection by Mark R. Schleiss

    Published 2013-01-01
    “…Fetal and neonatal infections caused by human cytomegalovirus (CMV) are important causes of morbidity and occasional mortality. Development of a vaccine against congenital CMV infection is a major public health priority. …”
    Get full text
    Article
  15. 1715
  16. 1716

    Nonhuman primate antigenic cartography of SARS-CoV-2 by Annika Rössler, Antonia Netzl, Ninaad Lasrado, Jayeshbhai Chaudhari, Barbara Mühlemann, Samuel H. Wilks, Janine Kimpel, Derek J. Smith, Dan H. Barouch

    Published 2025-01-01
    “…We also found that the monovalent XBB.1.5 mRNA vaccine induced broad immunity against the mapped antigenic space. …”
    Get full text
    Article
  17. 1717
  18. 1718
  19. 1719
  20. 1720